comparemela.com
Home
Live Updates
Promontory Therapeutics to Present Research on PT-112 in Adv
Promontory Therapeutics to Present Research on PT-112 in Adv
Promontory Therapeutics to Present Research on PT-112 in Advanced Non-Small Cell Lung Cancer at the ESMO Immuno-Oncology Congress 2022
NEW YORK, Nov. 30, 2022 /PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunothera...
Related Keywords
Switzerland ,
United States ,
China ,
Germany ,
Geneva ,
Genè ,
Canada ,
Brooke Raphael ,
Martina Imbimbo ,
Stephanie Carrington ,
Alexis Feinberg ,
Promontory Therapeutics Inc ,
Prnewswire Promontory Therapeutics Inc ,
Merck Kga ,
Oncology Congress ,
Palexpo Exhibition Centre ,
European Society For Medical Oncology Immuno ,
Merck Kgaa ,
Lausanne University Hospital ,
Serono ,
Virtual Congress ,
Therapeutics Inc ,
European Society ,
Medical Oncology Immuno ,
Palexpo Exhibition ,
Lead Author ,
Promontory Therapeutic ,
Developmental Therapeutics ,
Orphan Drug ,
Promontory Therapeutics ,